Sign in Pull a receipt

APRE

Aprea Therapeutics, Inc.

Healthcare · Biotechnology

$51.50 sample

+0.63 (+1.24%) 1D

Market cap

$62.7B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-14

Alerts

8

Price$51.50 +10.04% 3M daily closessample

52.0246.80

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider sell: EVP, Operations
Oct 19INSInsider buy: EVP, Operations
Oct 14SECDEF 14A filed
Oct 05INSInsider buy: Chief Executive Officer
Sep 29INSInsider sell: EVP, Operations
Sep 22INSInsider buy: Chief Financial Officer
Sep 15SEC10-Q filed
Sep 07INSInsider sell: General Counsel

Sign up to see the real APRE record →

Company facts

SEC EDGAR registration

Name: Aprea Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +57sample, -100 to +100
Reporting currency: USD

Who is positioning in APRE

sample

Insiders: 8 insider transactions over 90 days, net selling, $889.7M
Congress: No member trades over 90 days
Institutions · 13F: 24 funds hold $743.3M
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$2.6B +17.2% y/y

Q4 2024Q3 2026

Inventory$1.5B +9.0% y/y

Q4 2024Q3 2026

Accounts receivable$1.1B +3.7% y/y

Q4 2024Q3 2026

Total debt$2.9B +8.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $29.1B -9.8% 3M
Sample peer B: $30.9B +4.3% 3M
Sample peer C: $18.8B -12.4% 3M
Sample peer D: $36.6B +11.9% 3M
Sample peer E: $50.9B -8.0% 3M